Cell Cryopreservation Consumables Market (2026 - 2033)

Cell Cryopreservation Consumables Market Summary

The global cell cryopreservation consumables market size was valued at USD 1.6 billion in 2025 and is projected to grow from USD 1.7 billion in 2026 to USD 3.7 billion by 2033, at a CAGR of 11.3% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 40.4% in 2025. The growth is driven by the increasing adoption of cell and gene therapies, biobanking, and stem cell research.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

To learn more about this report, Download Free Sample Report

Market Dynamics

The industry is witnessing strong growth, driven by the rising demand for reliable long-term cell storage, advancements in cryopreservation technologies, and increasing adoption of standardized cell banking workflows, which are supporting market expansion. Furthermore, growing investments in biotechnology and life sciences research are expected to create new opportunities for market growth.

Market Concentration & Characteristics

The industry is characterized by a high degree of innovation, driven by advancements in cryopreservation media, controlled-rate freezing, closed-system solutions, and technologies that improve post-thaw cell viability. Manufacturers are increasingly developing specialized formulations tailored to different cell types and applications, including stem cells, immune cells, and cell therapy products. For instance, in April 2024, Pluristyx launched its PluriFreeze cryopreservation medium, designed to support the freezing and thawing of pluripotent stem cells and other energetically active cells while maintaining their viability and functionality, highlighting continued innovation in cell preservation solutions.

The industry is experiencing moderate M&A activity, with companies pursuing acquisitions to strengthen their cryopreservation technology portfolios and expand capabilities in cell and tissue preservation. For instance, in April 2025, BioLife Solutions acquired PanTHERA CryoSolutions, adding ice recrystallization inhibitor technology to improve cell survival and functionality during freezing and thawing.

To learn more about this report, Download Free Sample Report

“This acquisition is an extension of our strategy to strengthen BioLife's leadership position as a pure play consumables provider and enabler of advanced therapies. PanTHERA's differentiated IRI technology enhances our core capabilities in biopreservation, and their talented scientific team shares our commitment to deliver innovative, enabling solutions for the fast-growing CGT market.”

- Roderick de Greef, BioLife Chairman and CEO

The industry is influenced by quality, sterility, traceability, and GMP requirements, particularly for consumables used in cell and gene therapy manufacturing and clinical applications. The increasing commercialization of cell-based therapies is driving demand for validated, standardized, and closed-system consumables that maintain cell integrity throughout processing, storage, and transportation. In addition, regulatory and quality requirements are encouraging manufacturers to develop consumables that are compatible with controlled, reproducible workflows.

The industry is witnessing high product expansion, with manufacturers broadening portfolios across cryogenic vials, cryopreservation bags, preservation media, controlled-rate freezing containers, and automated fill-and-finish consumables. For instance, in March 2025, Teknova and Pluristyx launched the PluriFreeze cryopreservation system, designed to support large-scale, automated, and banking processes for allogeneic cell therapies.

The industry is experiencing moderate to high regional expansion, supported by growth in cell therapy manufacturing and regenerative medicine infrastructure. The expansion of localized cell-processing capabilities is increasing demand for standardized cryopreservation consumables across emerging and established markets.

Analyst Perspective

The market is expected to grow strongly, driven by increasing adoption of cell-based research, biobanking, regenerative medicine, and cell & gene therapies. Rising demand for long-term preservation of viable cells is accelerating the use of cryopreservation media, bags, vials, and related consumables across research and clinical workflows. Advancements in cryopreservation technologies, growing biopharmaceutical investments, and the expansion of cell therapy manufacturing are expected to support market growth.

Product Insights

The cryogenic tubes segment accounted for the largest revenue share of 19.0% in 2025, driven by their extensive application in the long-term storage and preservation of biological samples, cells, and tissues at ultra-low temperatures. Increasing cell-based research, biobanking activities, and the growing adoption of cell and gene therapies have further supported demand for durable, contamination-resistant, and reliable cryogenic storage consumables.

The cryogenic plates segment is expected to register the fastest CAGR over the forecast period, driven by increasing demand for high-throughput cell preservation and sample processing in biobanking, drug discovery, and cell-based research. The growing adoption of microplate-based workflows, which enable simultaneous handling of multiple samples and improve processing efficiency, is further supporting the adoption of cryogenic plates.

Cell Type Insights

The stem cells segment dominated the market with a 19.2% share in 2025, driven by the expanding use of stem cells in regenerative medicine, cell-based research, and therapeutic development, along with increasing investments in stem cell banking and biobanking infrastructure. According to an article published in Frontiers in February 2026, researchers evaluated a DMSO-free cryopreservation reagent for establishing a mesenchymal stem cell bank platform, demonstrating improved pre-freeze stability, post-thaw recovery, and expansion potential, thereby highlighting the growing focus on advanced cryopreservation solutions for stem cell banking and manufacturing.

The reproductive cells segment is expected to register the fastest CAGR over the forecast period, driven by the increasing adoption of fertility preservation and assisted reproductive technologies, including cryopreservation of oocytes, sperm, and embryos. Rising fertility-related challenges, growing demand for elective fertility preservation, and the expanding use of cryopreserved reproductive cells in IVF procedures are expected to further support segment growth.

End Use Insights

The biopharmaceutical & biotechnology companies segment dominated the market with a share of 23.1% in 2025, driven by the increasing use of cryopreserved cells in biologics development, cell-based therapies, and biopharmaceutical manufacturing. Growing investments in cell and gene therapy pipelines and the need to maintain cell viability, consistency, and functional integrity across research and manufacturing workflows further supported demand for cryopreservation consumables.

To learn more about this report, Download Free Sample Report

The cell banks & biobanks segment is projected to witness the fastest CAGR, driven by increasing investments in large-scale biobanking infrastructure and the growing use of biological samples for precision medicine, disease research, and proteomics. For instance, in April 2026, Thermo Fisher Scientific announced a strategic collaboration with PRECISE-SG100K Singapore to advance a population-scale biobank initiative, reflecting growing investments in national biobanking programs and supporting the need for efficient long-term preservation and management of biological samples.

Regional Insights

The North America cell cryopreservation consumables industry accounted for the largest revenue share of 40.4% in 2025, supported by established cell therapy and life sciences infrastructure in the region. In July 2026, Azenta Life Sciences introduced CoolCell cell freezing containers, which enable alcohol-free, standardized controlled-rate freezing and are designed to improve cryopreservation consistency and cell sample integrity. The development highlights continued adoption of advanced cryopreservation consumables across research, biopharmaceutical, and clinical applications in the region.

To learn more about this report, Download Free Sample Report

“CoolCell Cell Freezing Containers provide researchers with a simple, reliable solution for standardized controlled-rate freezing without the need for alcohol or programmable freezers. By delivering consistent cooling performance while eliminating the use of up to 12 liters of isopropanol per unit each year, CoolCell helps laboratories improve workflow consistency, reduce operating costs and protect valuable cell samples.”

- Alexis MacLeod, Global Product Manager – Consumables & Instruments at Azenta Life Sciences

U.S. Cell Cryopreservation Consumables Market Trends

The cell cryopreservation consumables industry in the U.S. is expected to grow significantly over the forecast period, supported by the growing commercialization of cell-based therapies and increasing demand for validated biopreservation solutions across clinical and manufacturing workflows. For instance, in February 2026, CaseBioscience launched CaseCryo CTG DMSO cryopreservation media and CaseStor HSS, designed to support cell therapy manufacturing and improve cell survival and functional performance after thawing. The development highlights the continued expansion of specialized cryopreservation consumables for advanced cell therapy applications.

Europe Cell Cryopreservation Consumables Market Trends

The cell cryopreservation consumables market in Europe was identified as a lucrative region in this industry, supported by the increasing standardization of cell preservation practices. For instance, in February 2025, the ALLTogether Consortium published recommendations in the British Journal of Cancer to harmonize biobanking practices across participating European countries, including standardized cryopreservation of viable leukemia cells and storage in multiple cryovials. The initiative highlights growing demand for reliable cryogenic storage consumables and standardized preservation workflows across European biobanks.

The UK cell cryopreservation consumables market is supported by expanding advanced therapy manufacturing and established cryogenic storage infrastructure. For instance, in July 2025, Cell and Gene Therapy Catapult, Cellular Origins, and Resolution Therapeutics formed a consortium to develop a fully automated robotics-based cell therapy manufacturing platform, incorporating closed processing and advanced manufacturing capabilities. The development is expected to strengthen the UK’s cell therapy manufacturing ecosystem and support demand for standardized cryopreservation consumables compatible with automated workflows.

Asia Pacific Cell Cryopreservation Consumables Market Trends

The cell cryopreservation consumables market in Asia-Pacific is expected to grow at the fastest CAGR of 12.2% during the forecast period, supported by expanding cell therapy manufacturing and regenerative medicine activities. For instance, in August 2025, Porton Advanced and Cellstore entered into a strategic collaboration in China to optimize cryopreservation technologies for cell therapy drugs, including the development of specialized cryopreservation media compatible with automated production. The collaboration highlights the increasing demand for advanced, application-specific cryopreservation consumables across the region.

The China cell cryopreservation consumables market is witnessing increasing standardization, supported by the expansion of cell therapy and biobanking applications. For instance, in December 2025, the Shanghai Medical Quality Association issued T/SHQAP 020-2025, a standard specifically for cell cryopreservation bags that establishes requirements for materials, physical properties, foreign particles, transparency, and heat-sealing strength. The standard, which took effect in January 2026, is expected to support greater consistency and quality assurance for cell cryopreservation consumables in China.

The cell cryopreservation consumables market in Japan is expected to grow steadily, supported by the growing adoption of automated cell preservation systems. Nippon Sanso has sold approximately 90,000 cryopreservation containers in Japan and has about 50% domestic market share, while its CryoLibrary system enables automated management and cryopreservation of biological samples in vials and vial boxes. These developments highlight the established use of specialized cryopreservation containers and automated storage solutions in Japan.

Latin America Cell Cryopreservation Consumables Market Trends

The cell cryopreservation consumables market in Latin America is expected to grow gradually, supported by the region’s relatively developed life sciences and clinical research ecosystems. Increasing the localization of laboratory capabilities and improvements in sample management practices are expected to support the adoption of standardized cryopreservation consumables.

Middle East & Africa Cell Cryopreservation Consumables Market Trends

The cell cryopreservation consumables market in the Middle East & Africa is expected to grow steadily, with demand concentrated in countries with comparatively advanced healthcare and research infrastructure. Increasing availability of specialized laboratory equipment and improvements in biological sample handling are expected to gradually expand the addressable market for cryopreservation consumables.

Key Cell Cryopreservation Consumables Company Insights

Several well-established companies operate in the market, supported by their portfolios of cryogenic vials, tubes, cryopreservation bags, straws, and other specialized cell preservation consumables. Leading players maintain a strong market presence through product innovation, expansion of cryopreservation portfolios, development of application-specific solutions, and strategic initiatives focused on improving cell viability, preservation consistency, scalability, and cell therapy manufacturing workflows.

Key Cell Cryopreservation Consumables Companies

The following key companies have been profiled for this study on the cell cryopreservation consumables market:

• Corning Incorporated

• Thermo Fisher Scientific Inc.

• Merck KGaA

• Azenta US Inc.

• Greiner Bio-One International GmbH

• Saint-Gobain

• OriGen Biomedical, Inc.

• CellBios

• Miltenyi Biotec

• Pluristyx, Inc.

• BioLife Solutions

• HOH Cells

Recent Developments

• In March 2026, OriGen Biomedical introduced O-Wrap Bags to reduce cryopreservation bag breakage by providing a protective barrier for freezing bags during cryogenic storage, with EVO copolymer construction enabling flexibility and protection at temperatures as low as −196°C.

• In March 2026, HOHCells launched FreezOpt in the U.S., a patented cryovial insert designed to control ice nucleation during cell cryopreservation, thereby improving freezing consistency, post-thaw viability, and reproducibility across biological research and cell therapy workflows.

• In May 2024, BioLife Solutions introduced the CellSeal CryoCase in Vancouver, Canada, as a rigid, cryo-compatible primary container designed to replace cryopreservation bags, support closed-system processing, improve product integrity, and reduce particulate-related risks in cell and gene therapy manufacturing.

Global Cell Cryopreservation Consumables Market Report Segmentation

This report forecasts revenue growth at the global, regional and country levels and provides an analysis on the latest trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global cell cryopreservation consumables market report based on product, cell type, end use, and region:

To learn more about this report, Download Free Sample Report

• Product Outlook (Revenue, USD Billion, 2021 - 2033)

  • Cryogenic Vials

  • Cryogenic Tubes

  • Cryopreservation Bags

  • Cryogenic Straws

  • Cryogenic Plates

  • Others

• Cell Type Outlook (Revenue, USD Billion, 2021 - 2033)

  • Stem Cells

  • Immune Cells

  • Primary Cells

  • Cancer Cells

  • Reproductive Cells

  • Other Cells

• End Use Outlook (Revenue, USD Billion, 2021 - 2033)

  • Biopharmaceutical & Biotechnology Companies

  • Research & Academic Institutes

  • Hospitals & Clinics

  • Cell Banks & Biobanks

  • Others

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

Research Methodology

The cell cryopreservation consumables market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing—reconciling supply-side and demand-side estimates—and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each cell cryopreservation consumables segment quantified using the revenue-capture definitions in the table below.

Delivered Customizations

This report has been delivered with the following In-depth customizations